The Schwartz-Jampel syndrome: Case report and review of literature

Authors
Keivan Basiri 1
Farzad Fatehi 2
Bashar Katirji 3
1 Isfahan Neurosciences Research Center, Alzahra Hospital, Department of Neurology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
2 Iranian Center of Neurological Research, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
3 Department of Neurology, Neuromuscular Center and EMG Laboratory, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
Abstract
Schwartz-Jampel syndrome (SJS), first described in the United States in 1962, is a hereditary disorder characterized by facial dysmorphism and muscle stiffness. We describe the first case of a Persian 9-year-old boy with SJS and review the literature. The child had a short neck, blepharophimosis, flattened face, hypertrichosis of the eyelids, prominent eyebrows, high arched palate, low set ears, micrognathia, short stature, and skeletal deformities. He had proximal muscle hypertrophy, distal muscle wasting and generalized hyporeflexia. Bone X-ray revealed pseudofracture of humerus. Needle electromyography revealed continuous myotonic discharges at rest with no waxing and waning in all tested muscles. Based on clinical and electrodiagnostic findings, the diagnosis of SJS type 1B was made and procainamide was started which resulted in clinical improvement. The diagnosis of SJS should be suspected when a child presents with the triad of myotonia, facial dysmorphism and skeletal deformities.

Keywords

1.
Giedion A, Boltshauser E, Briner J, Eich G, Exner G, Fendel H, et al. Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediatr 1997;156:214-23.  Back to cited text no. 1
    
2.
Reither M, Urban M, Kozlowski KS, Pritsch M, Tegtmeyer FK. Stüve-Wiedemann syndrome in two siblings: Focusing on a male patient with the longest actual survival rate. Klin Padiatr 2006;218:79-84.  Back to cited text no. 2
    
3.
Pascuzzi RM, Gratianne R, Azzarelli B, Kincaid JC. Schwartz-Jampel syndrome with dominant inheritance. Muscle Nerve 1990;13:1152-63.  Back to cited text no. 3
    
4.
Kulkarni ML, Pillai R. Schwartz-Jampel syndrome. Indian Pediatr 2004;41:285.  Back to cited text no. 4
    
5.
Pfeiffer RA, Bauer H, Petersen C. The Schwartz-Jampel syndrome (myotonia chondrodystrophica). Helv Paediatr Acta 1977;32:251-61.  Back to cited text no. 5
    
6.
Van Meir N, De Smet L. Carpal tunnel syndrome in children. Acta Orthop Belg 2003;69:387-95.  Back to cited text no. 6
    
7.
Oue T, Nishimoto M, Kitaura M, Samuta T, Toda N, Koyama Y, et al. Anesthetic management of a child with Schwartz-Jampel syndrome. Masui 2004;53:782-4.  Back to cited text no. 7
    
8.
Ferrannini E, Perniola T, Krajewska G, Serlenga L, Trizio M. Schwartz-Jampel syndrome with autosomal-dominant inheritance. Eur Neurol 1982;21:137-46.  Back to cited text no. 8
    
9.
Nicole S, Ben Hamida C, Beighton P, Bakouri S, Belal S, Romero N, et al. Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping. Hum Mol Genet 1995;4:1633-6.  Back to cited text no. 9
    
10.
Nicole S, Davoine CS, Topaloglu H, Cattolico L, Barral D, Beighton P, et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000;26:480-3.  Back to cited text no. 10
    
11.
French MM, Smith SE, Akanbi K, Sanford T, Hecht J, Farach-Carson MC, et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro. J Cell Biol 1999;145:1103-15.  Back to cited text no. 11
    
12.
Schofield KP, Gallagher JT, David G. Expression of proteoglycan core proteins in human bone marrow stroma. Biochem J 1999;343:663-8.  Back to cited text no. 12
    
13.
Brown AJ, Alicknavitch M, D'Souza SS, Daikoku T, Kirn-Safran CB, Marchetti D, et al. Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation. Bone 2008;43:689-99.  Back to cited text no. 13
    
14.
Lucci LM, Yen MT, Anderson RL, Hwang IP, Black RE. Orbicularis myectomy with levator advancement in Schwartz-Jampel syndrome. Am J Ophthalmol 2001;132:799-801.  Back to cited text no. 14
    
15.
Vargel I, Canter HI, Topaloglu H, Erk Y. Results of botulinum toxin: An application to blepharospasm Schwartz-Jampel syndrome. J Craniofac Surg 2006;17:656-60.  Back to cited text no. 15
Advanced Biomedical Research
Volume 2015, August
August 2015
Pages 1-3